News

Pterostilbene emulsion visibly reduced forehead and under-eye wrinkles ...
(9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase III clinical trial (AK112-310/HARMONi-GI2) of ivonescimab, a ...
Hillhurst Biopharmaceuticals Inc. ("Hillhurst"), a clinical-stage biopharmaceutical company focused on developing novel oral liquid drug products based on known inhaled therapeutics, today announced ...
Ahead of the upcoming UN General Assembly to set a new vision for non-communicable diseases, the Global Self-Care Federation is calling for self-care strategies to be integrated ...
"There's no doubt the work we are doing at Mercy is improving patient care and reducing physician and provider burnout." Much of the recent work is tied to an AI assistant that generates office notes ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable ...
CNW/ - GSK announced today that Health Canada has approved Blenrep (belantamab mafodotin for injection) in combination with bortezomib and dexamethasone, or in combination with pomalidomide and ...
Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is pleased to announce its donation of 60 new computers to the Diocese of Srikakulam, furthering ...
Apnimed, Inc., a pharmaceutical company advancing an industry-leading pipeline of first-in-class oral therapies that address the root causes of obstructive sleep apnea (OSA) and other sleep-related ...
On Self-Care Day, learn how pausing, reflecting, and prioritizing yourself boosts health, closes gaps, and strengthens global ...
Banana and broccoli extracts show potential to reduce anxiety, depression, and brain inflammation while improving memory, ...
HIV drugs can prevent HTLV-1 transmission and disease in mice, paving the way for trials to fight this long-overlooked, ...